FierceBiotech ٢٦ يناير ٢٠٢٦ 'Things are looking up': British biotechs consider going public after yearslong IPO drought
FierceBiotech ٢٣ يناير ٢٠٢٦ Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
FierceBiotech ٢٣ يناير ٢٠٢٦ Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings
FierceBiotech ٢٣ يناير ٢٠٢٦ J. Craig Venter launches genomics startup designed to boost diagnostic insights
FierceBiotech ٢٣ يناير ٢٠٢٦ Sanofi plans global filings for key eczema prospect despite mixed phase 3 readout
FierceBiotech ٢٢ يناير ٢٠٢٦ Corcept racks up phase 3 cancer win to bounce back from FDA Cushing's rejection
FierceBiotech ٢٢ يناير ٢٠٢٦ Corxel secures $287M series D to fund phase 2/3 obesity studies of oral GLP-1 drug
FierceBiotech ٢٢ يناير ٢٠٢٦ Hoth strikes back against cancer drug skin toxicities, but share price stays frozen
FierceBiotech ٢١ يناير ٢٠٢٦ Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
FierceBiotech ٢١ يناير ٢٠٢٦ FDA outlines draft policy on MRD, complete response for accelerated approvals in multiple myeloma
FierceBiotech ٢١ يناير ٢٠٢٦ IO mulls more layoffs months after halving head count in wake of cancer vaccine setback
FierceBiotech ٢١ يناير ٢٠٢٦ Touching base: Beam CEO on gene editing biotech's 'big push' for in vivo delivery
FierceBiotech ٢١ يناير ٢٠٢٦ Novo Nordisk offloads diabetes assets to Aspect amid cell therapy retreat